BUN/Creatinine Ratio

Lipoprotein(a) [Lp(a)]

BUN (Blood Urea Nitrogen)

Homocysteine

HS-CRP (High-Sensitivity C-Reactive Protein)

Neutrophils (Absolute)

Total Testosterone

Sed Rate (Erythrocyte Sedimentation Rate)

Serum Iron

GGT (Gamma-Glutamyl Transferase)

DHEA-S (Dehydroepiandrosterone Sulfate)

NRBC (Nucleated Red Blood Cells)

EPA (Eicosapentaenoic Acid)

LDH (Lactate Dehydrogenase)

Lymphocytes (Absolute)

Eosinophils (Absolute)

Calcium

LDL Cholesterol (calculated)

TPO Ab (Thyroid Peroxidase Antibodies)

Lactic Acid

eGFR (Estimated Glomerular Filtration Rate)

Basophils (Absolute)

ApoA/ApoB Ratio

WBC (White Blood Cell Count)

Serum Cortisol

LDL Particle Size

Bicarbonate

IL-6 (Interleukin-6)

RDW (Red Cell Distribution Width)

ALT (Alanine Aminotransferase)

RBC (Red Blood Cell Count)

Potassium

MCHC (Mean Corpuscular Hemoglobin Concentration)

Copper Serum

Tg Ab (Thyroglobulin Antibodies)

Platelet Count

Bilirubin (Total and Direct)

Glucose

Total Protein

AST (Aspartate Aminotransferase)

Discover the significance of fibrinogen as a biomarker for longevity. Learn how monitoring this protein can provide valuable insights into aging and disease risk.

Fibrinogen

In the study of longevity, biomarkers play a crucial role in assessing an individual’s health and predicting their potential lifespan. One such biomarker is fibrinogen, a protein found in blood plasma that plays a key role in blood clotting. Elevated levels of fibrinogen have been associated with an increased risk of cardiovascular disease and mortality, making it an important biomarker to monitor for longevity purposes. By tracking fibrinogen levels over time, researchers and healthcare professionals can gain valuable insights into an individual’s cardiovascular health and overall risk of age-related diseases, offering potential opportunities for intervention and improved longevity.

Biomarker Explained

Biomarkers are essential tools in the study of longevity, providing valuable insight into an individual’s health and potential lifespan. One such biomarker is fibrinogen, a protein found in blood plasma with a significant role in blood clotting. Elevated levels of fibrinogen have been linked to an increased risk of cardiovascular disease and mortality, making it a crucial biomarker to monitor for longevity purposes. Interpreting fibrinogen levels involves tracking its concentration in the blood over time. Elevated levels may indicate a higher risk of cardiovascular disease and mortality, suggesting a potential need for intervention to improve overall longevity. By monitoring fibrinogen levels, researchers and healthcare professionals can gain important insights into an individual’s cardiovascular health and overall risk of age-related diseases. Understanding and interpreting fibrinogen levels allows for the identification of potential opportunities for intervention, such as lifestyle modifications or targeted medical treatments, to improve an individual’s longevity. By leveraging the insights provided by fibrinogen as a biomarker, healthcare professionals can work towards implementing proactive measures to optimize cardiovascular health and overall longevity.

Keywords:

biomarker, longevity, fibrinogen, blood plasma, cardiovascular disease, mortality, intervention, concentration, healthcare professionals, age-related diseases, lifestyle modifications, medical treatments, proactive measures, cardiovascular health.

Contact

Questions, suggestions, reflections?

Fill out the form below and a member of our team well get back to you as soon as possible.

Contact Form (#14)

How does Rapaymcin work?

Rapamycin slows aging by targeting the mTOR pathway, shifting the body’s focus from growth to repair. It promotes cellular recycling, reduces overgrowth linked to disease, and enhances resilience to stress.

Imagine your body as a city, bustling with activity.

Cells are the workers, and mTOR (mechanistic target of rapamycin) is the city planner, deciding where to focus resources – building new structures, cleaning up waste, or repairing old ones.

As we age, mTOR often prioritizes building (cell growth) over maintenance (cellular repair), leading to “clutter” in our bodies that contributes to aging and disease.

This is where Rapamycin comes in.

It acts like a wise advisor to mTOR, convincing it to slow down unnecessary growth projects and focus on clean up and repair instead.

Specifically, Rapamycin:

Activates cellular recycling (autophagy):

Think of autophagy as the city’s waste management system. Damaged parts of cells are broken down and reused, keeping the system efficient and healthy.

Reduces harmful overgrowth:

Overactive mTOR has been linked to diseases such as cancer, cardiovascular disease, and neurodegenerative conditions like Alzheimer’s. By dialing back excessive growth signals, Rapamycin helps prevent these issues.

Supports stress resilience:

When cells are less focused on growing, they’re better equipped to handle stress, repair damage, and maintain long-term health.